| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/2004 | US20040091430 Aqueous slurries useful for cleaning the tongue and throat and methods related thereto |
| 05/13/2004 | US20040091428 Method of preventing and treating mucosal and dermal conditions |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | US20040091421 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
| 05/13/2004 | US20040089753 Wet milling process |
| 05/13/2004 | US20040089604 Solution for peritoneal dialysis |
| 05/13/2004 | DE4034090B4 Verwendung von Ginkgoliden und Triazolothienodiazepinen zur Behandlung der Blutplättchenaggregation in Gegenwart von LDL und LA-paf Use of ginkgolides and Triazolothienodiazepinen for the treatment of platelet aggregation in the presence of LDL and LA-paf |
| 05/13/2004 | DE20220744U1 Mittel zur Hemmung von Lentiviren Means for inhibiting lentiviruses |
| 05/13/2004 | DE10262018A1 Kondensierte Palatinose und Verfahren zu deren Herstellung Condensed palatinose and processes for their preparation |
| 05/13/2004 | DE10251256A1 Transdermales Wirkstoffabgabesystem für Oxybutynin Transdermal drug delivery system for oxybutynin |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | DE10250687A1 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung 7H-dibenzo (b, g) (1.5) dioxocin-5-one derivatives and their use |
| 05/13/2004 | DE10250646A1 Cosmetic and/or pharmaceutical hair treatment compositions, especially for promoting hair growth, containing melatonin (or derivative) and Gingko biloba and biotin as potentiating agents |
| 05/13/2004 | DE10250082A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10250081A1 Wasserlösliche Meloxicam Granulate Water soluble meloxicam granules |
| 05/13/2004 | DE10249552A1 Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel Water-soluble iron-carbohydrate complexes, their preparation and pharmaceutical compositions containing them |
| 05/13/2004 | DE10240818A1 Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate Substituted 2-pyrrolidin-2-yl- [1,3,4] oxadiazol-derivatives |
| 05/13/2004 | CA2509834A1 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia |
| 05/13/2004 | CA2504682A1 Use of equol for treating androgen mediated diseases |
| 05/13/2004 | CA2504647A1 Compositions and methods for pain reduction |
| 05/13/2004 | CA2504511A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | CA2504388A1 Quinazolinone compositions for regulation of gene expression related to pathological processes |
| 05/13/2004 | CA2504361A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | CA2504341A1 Melatonin daily dosing units |
| 05/13/2004 | CA2503962A1 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls |
| 05/13/2004 | CA2503956A1 Propofol with cysteine |
| 05/13/2004 | CA2503881A1 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 05/13/2004 | CA2503841A1 Therapeutic compositions |
| 05/13/2004 | CA2503693A1 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/13/2004 | CA2503616A1 Treatment of pain with jnk inhibitors |
| 05/13/2004 | CA2503489A1 Modulation of zinc levels to improve tissue properties |
| 05/13/2004 | CA2503381A1 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof |
| 05/13/2004 | CA2503121A1 Pulsatile release compositions of milnacipran |
| 05/13/2004 | CA2502837A1 Aryl phosphate derivatives of d4t having activity against resistant hiv strains |
| 05/13/2004 | CA2502833A1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 05/13/2004 | CA2500850A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 05/13/2004 | CA2500487A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 05/13/2004 | CA2498261A1 Use of piperazine derivatives as ccr1 antagonists |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/12/2004 | EP1418428A1 Method to provide natural therapeutic agents with high therapeutic index |
| 05/12/2004 | EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression |
| 05/12/2004 | EP1418177A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1418175A1 Respiratory syncytial virus replication inhibitors |
| 05/12/2004 | EP1418174A2 Amorphous Ritonavir |
| 05/12/2004 | EP1418164A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists |
| 05/12/2004 | EP1417976A1 Remedy for glaucoma comprising as the active ingredient compound having pi3 kinase inhibitory effect |
| 05/12/2004 | EP1417975A1 REMEDIES FOR DISEASES WITH BONE MASS LOSS HAVING EP sb 4 /sb AGONIST AS THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417970A2 Anti-allergic, anti-bacteric and anti-redden compound for eyes |
| 05/12/2004 | EP1417969A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application |
| 05/12/2004 | EP1417968A2 Antitumour compositions containing propolis and resveratrol |
| 05/12/2004 | EP1417967A1 Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
| 05/12/2004 | EP1417966A1 Flavonol glycosides as neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 05/12/2004 | EP1417965A1 C-type lectin binding molecules, identification and uses thereof |
| 05/12/2004 | EP1417964A1 Antitumor agent containing cyclic polylactic acid |
| 05/12/2004 | EP1417963A1 Highly purified EPA and derivatives for psychiatric and neurological disorders |
| 05/12/2004 | EP1417962A1 Method for the manufacture of a medicament comprising esmolol |
| 05/12/2004 | EP1417961A1 New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide |
| 05/12/2004 | EP1417960A1 Sustained release micropellets and process for producing the same |
| 05/12/2004 | EP1417959A1 Tablet for buccal, sublingual or gingival administration, comprising an effervescent couple |
| 05/12/2004 | EP1417958A1 Wet granulation process |
| 05/12/2004 | EP1417955A1 Humectant and cosmetics and external preparations containing the same |
| 05/12/2004 | EP1417351A2 Antisense modulation of apolipoprotein(a) expression |
| 05/12/2004 | EP1417350A2 Antisense modulation of hormone-sensitive lipase expression |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417308A1 Human protooncogene kg-20 and protein encoded therein |
| 05/12/2004 | EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1417214A2 Cancer specific oligosaccharide sequences and use thereof |
| 05/12/2004 | EP1417211A2 Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| 05/12/2004 | EP1417208A1 Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| 05/12/2004 | EP1417206A1 NOVEL 2 i H /i -PYRIDAZINE-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND A PROCESS FOR THE PREPARATION OF THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417203A1 S-6-hydroxy-buspirone |
| 05/12/2004 | EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417200A2 Substituted 1h-dihydropyrazoles, their preparation and use |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417195A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417189A1 Acylaminothiazole derivatives, their preparation and therapeutic use |
| 05/12/2004 | EP1417188A1 Novel 2,4-diaminothiazole derivatives |
| 05/12/2004 | EP1417187A1 Aryl substituted thiazolidinones and the use thereof |
| 05/12/2004 | EP1417186A2 Heterocyclic aryl sulphonamides |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417179A1 Polymorph salt of a pyridazinone derivative for the treatment of arrhythmia |
| 05/12/2004 | EP1417177A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 05/12/2004 | EP1417176A1 Substituted anthranilamides for controlling invertebrate pests |
| 05/12/2004 | EP1417175A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates, their preparation and use |
| 05/12/2004 | EP1417174A2 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417172A1 Process for the preparation of amorphous form of torsemide |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1416990A1 Inhalation device with a pharmaceutical composition |